Semmelweis University
- Country
- 🇭🇺Hungary
- Ownership
- Private, Subsidiary
- Established
- 1769-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.sote.hu
Clinical Trials
115
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (83 trials with phase data)• Click on a phase to view related trials
Subcutaneous Intersectional Short Pulse Stimulation in Epileptic Patients
- Conditions
- Epilepsy
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 30
- Registration Number
- NCT07041619
- Locations
- 🇭🇺
Semmelweis University Neurosurgery and Neurointerventional Clinic, Budapest, Hungary
Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients
- Conditions
- Acute Bronchitis
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 56
- Registration Number
- NCT07030855
- Locations
- 🇭🇺
Noé Medical Center, Szeged, Hungary
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
- Conditions
- Coronary Artery DiseaseAortic Valve StenosisTomography, X-Ray Computed
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 1000
- Registration Number
- NCT07016477
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇩🇪Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
🇩🇪University Medical Center Mainz, Mainz, Germany
Evaluation of Clinical and Radiological Outcomes Following the Treatment of Periodontal Intraosseous Defects Using Autogenous Tooth-derived Graft or Autogenous Bone Graft With Enamel Matrix Derivatives. A 12-month Randomized Controlled Clinical Trial.
- Conditions
- Periodontitis
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 60
- Registration Number
- NCT06991998
- Locations
- 🇭🇺
Semmelweis University, Department of Periodontology, Budapest, Hungary
The Comparison of Navigational Bronchoscopic and CT-Guided Preoperative Markings in Minimally Invasive Thoracic Surgery
- Conditions
- VATSLungICG (Indocyanine Green)
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Semmelweis University
- Target Recruit Count
- 81
- Registration Number
- NCT06957600
- Locations
- 🇭🇺
Semmelweis University- National Institute of Oncology Department of Thoracic Surgery, Budapest, Hungary
- Prev
- 1
- 2
- 3
- 4
- 5
- 22
- Next
News
Algernon NeuroScience Launches Phase 2a Trial of DMT for Stroke Recovery with Leading Neurologist
Algernon NeuroScience appoints Dr. Sándor Nardai to lead a groundbreaking Phase 2a clinical trial investigating DMT as a potential stroke recovery treatment, set to begin in Q3 2025.